ArticleCancer chemotherapy and pharmacology2021

Population pharmacokinetics and exposure-response of selumetinib and its N-desmethyl metabolite in pediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas.

Stein Schalkwijk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.